Sexual Dysfunction in Women Treated for Type 1 Diabetes and the Impact of Coexisting Thyroid Disease
- PMID: 30954495
- PMCID: PMC6523036
- DOI: 10.1016/j.esxm.2019.03.001
Sexual Dysfunction in Women Treated for Type 1 Diabetes and the Impact of Coexisting Thyroid Disease
Abstract
Introduction: More sexual problems are reported among people treated for diabetes; however, this situation is less explored in women than in men.
Aim: To analyze the presence and causal links of female sexual dysfunction (FSD) among Czech women treated for type 1 diabetes.
Methods: 40 women completed a national version of the Female Sexual Function Index (FSFI), Female Sexual Distress Scale-revised (FSDS-R), and Beck's Depression Inventory-II (BDI-II). A metabolic and endocrine analysis was done using blood samples. Data were statistically analyzed using SPSS v.24 and the R environment.
Main outcome measures: Patient details (personal information, diabetes-related data, and sex history), sexual performance (the FSFI and FSDS-R scores), and level of depression (the BDI-II score) were measured.
Results: FSD was present in 58% of the participants (based on the FSFI score), and 38% women declared significant sexual distress (according to their FSDS-R score). Even though only 4 women fulfilled the criteria for depression, we observed a strong association between BDI-II and FSFI (for total FSFI score P = .012, ρ = -0.394) resp. FSDS-R scores (P < .001, ρ = 0.552). Although we were not able to establish a clear direct connection between FSD and metabolic control, BDI-II scores were closely correlated with glycosylated hemoglobin (P = .009, ρ = 0.407). The duration of diabetes (based on FSDS-R: P = .046) but neither age nor the presence of chronic diabetic microvascular complications was associated with a higher FSD occurrence. We also observed an association between FSD and the presence of autoimmune hypothyroidism, even when successfully treated (FSDS-R: P = .009; FSFI: P = .067).
Conclusion: FSD is more common in women with type 1 diabetes than in healthy women, and coexisting thyroid autoimmune disease seems to exacerbate FSD. Women suffering from type 1 diabetes, and particularly those with additional endocrinopathies, should be actively screened for FSD. Stechova K, Mastikova L, Urbaniec K, et al. Sexual Dysfunction in Women Treated for Type 1 Diabetes and the Impact of Coexisting Thyroid Disease. Sex Med 2019;7:217-226.
Keywords: Autoimmune Thyroid Disease; BDI-II; Diabetes; FSDS-R; FSFI; Female Sexual Dysfunction; Insulin; Insulin Pump; Life Quality; Sexarche.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
Figures



References
-
- World Health Organization Sexual and reproductive health, working definitions. http://www.who.int/reproductivehealth/topics/sexual_health/sh_definition... Available at:
-
- Morokqff P.J., Gillilland R. Stress, sexual functioning, and marital satisfaction. J Sex Res. 1993;30:43–53.
-
- Monga M., Alexandrescu B., Katz S.E. Impact of infertility on quality of life, marital adjustment, and sexual function. Urology. 2004;63:126–130. - PubMed
-
- Chen C.H., Lin Y.C., Chiu L.H. Female sexual dysfunction: Definition, classification, and debates. Taiwan J Obstet Gynecol. 2013;52:3–7. - PubMed
-
- Rosen R.C., Barsky J.L. Normal sexual response in women. Obstet Gynecol Clin N Am. 2006;33:515–526. - PubMed